Overall, it is proposed herein that activation of the GPCR oncogenes PAR4 and PAR2 potently induce lysine methylation of β-catenin by EZH2, promoting its sustained stability levels in colon cancer. Here, EZH2 is linked to malignant colon neoplasm.